Matches in Nanopublications for { ?s ?p "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP834297.RA1BBUewSISPlG_eMvPx8-GGQM6TWh1ssXkceB1N4OJTg130_assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834297.RA1BBUewSISPlG_eMvPx8-GGQM6TWh1ssXkceB1N4OJTg130_provenance.
- NP1011980.RAUb9vsMLFvie_vJk1bJh4uqb_dXd39UnD3ITUiOClhoM130_assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1011980.RAUb9vsMLFvie_vJk1bJh4uqb_dXd39UnD3ITUiOClhoM130_provenance.
- assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP851567.RANEvLZZRmmtJUXbxkKFbeE3oACder7zLY-xxoGPyqqJk130_assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP851567.RANEvLZZRmmtJUXbxkKFbeE3oACder7zLY-xxoGPyqqJk130_provenance.
- NP946254.RAj088GBcoyfT_VKogprI7kZe7vPJkX80XY8uYQRss4DY130_assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946254.RAj088GBcoyfT_VKogprI7kZe7vPJkX80XY8uYQRss4DY130_provenance.
- NP427863.RAKKB_gkKPtts4e9ebLYcIxUWTHnJD2BZvWHx-o6bWyXA130_assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427863.RAKKB_gkKPtts4e9ebLYcIxUWTHnJD2BZvWHx-o6bWyXA130_provenance.
- NP427861.RA1CuSrHuWbUDifb-JIratIDthwCfujy5CaTg9Vjyo758130_assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427861.RA1CuSrHuWbUDifb-JIratIDthwCfujy5CaTg9Vjyo758130_provenance.
- NP427862.RA9b3tg9lmIBBhneQFG2IeHdIsd1fi6Isovfb3W1CF5M8130_assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427862.RA9b3tg9lmIBBhneQFG2IeHdIsd1fi6Isovfb3W1CF5M8130_provenance.
- NP427865.RA_HRKz7J9508RBIEOnUN7iZ3gCiU4p43SM9XII9mFc-E130_assertion description "[In addition, (Pro9)GLP-1 showed significant ability to moderate the plasma glucose excursion and increase circulating insulin concentrations in severely insulin resistant obese diabetic (ob/ob) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427865.RA_HRKz7J9508RBIEOnUN7iZ3gCiU4p43SM9XII9mFc-E130_provenance.